1-6 of 6
Doris Soebbing
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Clinical Trial of "Off-the-Shelf" NK Cells with Allogeneic Stem Cell Transplantation to Decrease Disease Relapse in Patients with High-Risk Myeloid Malignancies

Jeremy L. Ramdial, Lorlyn Clemente-Sevilla, Doris Soebbing, Bouthaina S. Dabaja, Peter F Thall, Gheath Alatrash, Amin M Alousi, Rohtesh S. Mehta, Uday R Popat, Partow Kebriaei, Betul Oran, Katy Rezvani, Elizabeth J Shpall, Richard E Champlin
Journal: Blood
Blood (2022) 140 (Supplement 1): 7484–7485.
https://doi.org/10.1182/blood-2022-170663
Published: 2022
Journal Articles

Haploidentical Mbil-21 Ex Vivo Expanded NK Cells (FC21-NK) for Patients with Multiple Relapsed and Refractory Acute Myeloid Leukemia

Stefan O. Ciurea, MD, Jolie Schafer, Piyanuch Kongtim, MD, Julianne Chen, Doris Soebbing, Kai Cao, MS, MD, Samer A. Srour, MD MS, Elizabeth J. Shpall, MD, Marina Konopleva, MD PhD, Dean Anthony Lee, MD PhD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-134858
Published: 2020
Journal Articles

Improved Outcomes for Patients Receiving High-Doses of IL-21 Ex Vivo Expanded NK Cells after Haploidentical Transplantation (haploSCT): Long-Term Follow-up of a Phase 1/2 Clinical Trial with Comparison to CIBMTR Controls

Stefan O. Ciurea, MD, Roland Bassett, Doris Soebbing, Gabriela Rondon, MD, Kai Cao, MS, MD, Amanda L. Olson, MD, Qaiser Bashir, MBBS, Elizabeth J. Shpall, MD, Steven Devine, Marcelo C. Pasquini, MD, Andrew St. Martin, MS, Dean Anthony Lee, MD PhD, Richard E Champlin
Journal: Blood
Blood (2019) 134 (Supplement_1): 700.
https://doi.org/10.1182/blood-2019-123936
Published: 2019
Journal Articles

Interim Results of a Phase 2 Clinical Trial Using Mb-IL21 Ex Vivo Expanded NK Cells to Enhance Graft Versus Leukemia Effect for Patients with Myeloid Malignancies after Haploidentical Transplantation

Stefan O. Ciurea, Doris Soebbing, Gabriela Rondon, MD, Kai Cao, MS, MD, Gheath Alatrash, DO, PhD, Sairah Ahmed, Uday Popat, MD, Betul Oran, MDMS, Qaiser Bashir, MD MBBS, Partow Kebriaei, MD, Indreshpal Kaur, PhD, Katayoun Rezvani, MD PhD, Elizabeth J Shpall, MD, Dean Anthony Lee, MD PhD, Richard E. Champlin, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3179.
https://doi.org/10.1182/blood.V130.Suppl_1.3179.3179
Published: 2017
Journal Articles

Phase 1 clinical trial using mbIL21 ex vivo–expanded donor-derived NK cells after haploidentical transplantation

Clinical Trials & Observations
Stefan O. Ciurea, Jolie R. Schafer, Roland Bassett, Cecele J. Denman, Kai Cao, Dana Willis, Gabriela Rondon, Julianne Chen, Doris Soebbing, Indreshpal Kaur, Alison Gulbis, Sairah Ahmed, Katayoun Rezvani, Elizabeth J. Shpall, Dean A. Lee, Richard E. Champlin
Journal: Blood
Blood (2017) 130 (16): 1857–1868.
https://doi.org/10.1182/blood-2017-05-785659
Published: 2017
Includes: Supplemental data
Journal Articles

Safety and Feasibility of Administration of High Doses of Ex Vivo Expanded NK Cells for Prevention of Disease Relapse after Transplantation for Patients with Myeloid Malignancies - Final Results of a Phase I Clinical Trial

Stefan O. Ciurea, MD, Dean A. Lee, MD PhD, Cecele Denman, MS, Jolie Schafer, Roland L Bassett, Jr., Kai Cao, MS, MD, Gabriela Rondon, MD, Julianne Chen, Doris Soebbing, Dana B. Willis, Sairah Ahmed, MD, Qaiser Bashir, MD, Partow Kebriaei, MD, Issa F. Khouri, MD, Betul Oran, MD, Simrit Parmar, MD, Uday R. Popat, MD, Chitra Hosing, MD, Eric Yvon, PhD, Katayoun Rezvani, MD PhD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2016) 128 (22): 500.
https://doi.org/10.1182/blood.V128.22.500.500
Published: 2016